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Abstract  
Introduction. We developed a rat model of portal vein ligation (PVL) with venous 
congestion (PVL+C) to investigate beneficial effect PVL plus congestion for regeneration 
of intact liver segments.  
Materials and methods. In the PVL group, portal vein branches were ligated except the 
caudate lobe (CL). In the PVL+C group, the left lateral hepatic vein was ligated in 
addition to PVL. Chronological changes in the following variables were compared among 
the groups: CL weight to body weight ratio (CL/BW), embolized liver weight to body 
weight ratio (EL/BW), histological findings of the embolized/non-embolized liver, and 
expression of several mediators that affect liver regeneration in the non-embolized liver. 
Results. Weight regeneration of CL continued up to postoperative day (POD)7 in PVL+C, 
but terminated at POD2 in PVL. CL/BW at POD7 was significantly higher in PVL+C 
than in PVL (2.41±0.33% vs 1.22±0.18%, P<0.01). In contrast, EL/BW continued to 
decrease up to POD7 in PVL+C but reached nadir at POD2 in PVL. Furthermore, EL/BW 
at POD7 was significantly smaller in PVL+C than in PVL (0.35±0.03% vs 0.67±0.08%, 
P<0.01). Histologically-proven injury in the embolized liver was more severe in PVL+C 
than in PVL. Expression of Ki-67, IL-6, TNF-α, and HGF were greater and/or more 
prolonged in PVL+C than in PVL. 
Conclusions. Our rat model of PVL+C was considered useful for investigating the 
beneficial effect of congestion in addition to PVC. PVL+C caused increased devastation 
of the embolized liver, and higher and more prolonged expression of factors promoting 
liver regeneration in the non-embolized liver than in PVL. 
 
 
  
 
 
Introduction 
Despite the introduction of highly effective non-surgical treatments for malignant tumors, 
only a hepatectomy can currently provide the chance of a cure for patients with 
hepatobiliary malignancy (1-4). Portal vein embolization or ligation (PVE/L) has been 
widely used for securing the safety of a subsequent major hepatectomy as well as 
expanding hepatectomy indications for patients with livers severely affected by 
hepatobiliary malignancy due to its ability to regenerate non-embolized liver, i.e. future 
liver remnant (FLR). However, 14-37% of patients receiving PVE/L have abandoned 
surgery due to insufficient regeneration of the FLR as well as oncological deterioration 
during the interval between PVE/L and hepatectomy (5-7). 
To compensate the above-stated concerns regarding PVE/L, i.e. insufficient FLR 
regeneration and modest regeneration velocity requiring 3-4 weeks for sufficient 
regeneration, hepatic venous embolization combined with PVE/L and associating liver 
partition and portal ligation for staged hepatectomy (ALPPS) were introduced and have 
been applied worldwide (8,9). In these two novel approaches, congestion in addition to 
PVE/L has been considered to have a central role in enabling a beneficial effect for 
regeneration of the non-embolized liver in terms of resultant FLR hypertrophy and/or 
earlier expansion of FLR (10,11). A clinical study by Hwan et al. reported that congestion 
due to hepatic venous embolization performed subsequently to PVE/L caused greater 
FLR expansion than PVE/L alone (12). Furthermore, the earliness of FLR expansion 
and/or greater resultant of FLR brought on by ALPPS compared to PVE/L alone can be 
explained partly by partial congestion of the planned resected liver segments caused by 
venous disruption due to liver partition (10). 
  
 
Several animal models of PVE/L have been introduced to investigate the detailed 
mechanisms of the beneficial effect of PVE/L for regeneration of the non-embolized liver 
(13,14). However, to the best of our knowledge, an animal model of PVE/L with venous 
congestion to investigate the beneficial effect of congestion in addition to PVE/L has not 
yet been reported. In the present study, we developed a rat model of PVL with venous 
congestion (PVL+C) to determine the beneficial effect of congestion in addition to PVE/L 
in regeneration of the non-embolized liver in comparison PVL alone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Materials and methods 
Animals 
Eight-week-old male Wistar rats (Kureo, Tokyo, Japan) were housed in a room with a 12-
h light/dark cycle and given full access to tap water and laboratory food. During all 
experimental procedures, animals were treated in accordance with the guidelines outlined 
in the Guide for the Care and Use of Laboratory Animals that was prepared by the US 
National Academy of Sciences and published by the National Institutes of Health 
(Bethesda, MD). The experimental protocol was approved by our institutional animal care 
committee (protocol number: F-A-14-008). 
 
Experimental operative procedures 
The rat liver consists of four lobes (Fig. 1c): the right lobe (RL); the middle lobe, which 
includes the right middle lobe (RML) and the left middle lobe (LML); the left lateral lobe 
(LLL); and the caudate lobe (CL). Each lobe is supplied by its own portal pedicle and is 
drained by its own hepatic veins. 
Rats were assigned at random to one of three experimental groups: PVL, PVL+C, and 
sham operation (SHAM). All surgical procedures were performed under anesthesia with 
isoflurane (concentration, 1.5%) and oxygen (flow rate, 0.5 L/min). In the PVL group 
(Fig. 1a), selective PVL was performed to affect the RL, RML, LML, and LLL; after 
careful dissection sparing the hepatic arteries and bile ducts, portal veins corresponding 
to the lobes were ligated with 6-0 silk sutures. The CL was preserved and allowed to 
regenerate. In the PVL+C group (Fig. 1b), PVL was performed as described above. 
Venous congestion then was induced by ligation of the left lateral hepatic vein. Special 
attention was paid to secure the integrity of the portal branches feeding the CL via the 
  
 
PVL and not to cause stenosis of the inferior vena cava and/or other hepatic veins via the 
lateral hepatic vein ligation. In the SHAM group (Fig. 1c), the hepatic artery, PV, and bile 
duct were dissected without ligation, after which the abdomen was closed using double 
running sutures. 
Arterial circulation and biliary duct branches were maintained in all rats. In both 
procedures including PVL, preservation of arterial flow reduced likelihood of the liver 
parenchyma becoming totally ischemic with subsequent abscess formation. No deaths or 
serious complications occurred during the surgical procedures or subsequent 7-d 
observation period. 
 
Experimental design and tissue allocation 
Animals were weighed regularly. The 150 study rats were randomized into three groups 
of 50 each and sacrificed using a mixture of 4% isoflurane and saturated carbon dioxide 
atmosphere at different time intervals: immediately after surgery and 24 h, 48 h, 3 d, and 
7 d later (10 rats per group at each time point) (Figure 2). At the time of killing blood 
samples were collected from the abdominal aorta, and the entire liver was removed and 
divided into the RML, LML, LLL, RL, and CL, each of which was weighed. Samples of 
the lobes then were processed for histologic examination. In particular, approximately 
200 mg of liver tissue from the CL was fixed in 10% formalin solution or snap-frozen in 
liquid nitrogen, with the frozen samples stored at -80°C until use. 
To investigate the difference between PVL and PVL+C, the following variables were 
compared among the SHAM, PVL, and PVL groups. 
 
Histologic and immunohistochemical examination 
  
 
After immersion fixation in 10% formalin, liver tissues were embedded in paraffin and 
sectioned by routine methods. Some sections were stained with hematoxylin-eosin (HE). 
Additionally, the rate of liver regeneration was determined from the frequency of Ki-67-
positive cells as follows. Liver sections from the CL taken at 24 h, 48 h, 3 d, and 7 d after 
surgery were deparaffinized and rehydrated with xylene and a graded ethanol series. 
Antigen retrieval was performed by placement of sections in 10-mM sodium citrate buffer 
(pH 6.0) for treatment in a microwave oven at 121°C for 30 min. Endogenous peroxidase 
activity was quenched by immersion in 0.3% hydrogen peroxide in methanol for 30 min. 
Nonspecific binding sites then were blocked using a 10% rabbit serum solution for 15 
min at 37°C. Next, sections were incubated at room temperature for 1 h with a mouse 
monoclonal anti-rat Ki-67 antibody (DAKO Japan, Tokyo) diluted 1:25 in phosphate-
buffered saline. Sections were then incubated with peroxidase-labeled anti-mouse 
antibody (Dakocytomation EnVision1 System) according to the manufacturer’s 
instructions, followed by incubation with 3,3'-diaminobenzidine and counterstaining with 
Mayer’s hematoxylin. After Ki-67-positive hepatocytes were counted in 10 randomly 
chosen high-power fields from three sections per group, means were calculated for 
analysis. 
Hepatocytic apoptosis was assessed in sections from the LLL using the terminal 
deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) method, using an in situ 
cell death detection kit (Roche Diagnostics, Tokyo, Japan) according to the 
manufacturer’s instructions. After TUNEL-positive hepatocytes were counted in 10 
randomly chosen high-power fields from three sections per group, means were calculated 
for analysis. 
 
  
 
All histologic analyses were performed without knowledge of the experimental group. 
 
Blood laboratory tests 
Serum concentrations of alanine aminotransferase (ALT), aspartate aminotransferase 
(AST), and total bilirubin (T.Bil) were measured using standard laboratory methods. 
 
Real-time reverse-transcription polymerase chain reaction (RT-PCR) 
Cytokines that reportedly affected liver regeneration were assessed at the messenger RNA 
(mRNA) level determined by RT-PCR, which was performed in snap-frozen CL 
specimens obtained at 24 h, 48 h, 3 d, and 7 d after surgery. Expression of the following 
cytokines in the CL was investigated: tumor necrosis factor-α (TNF-α), interleukin-6 (IL-
6), cyclin C, cyclin D1, hepatocyte growth factor (HGF), and interleukin-1β (IL1-β). 
After total RNA was isolated from each sample using an RNAspin mini RNA isolation 
kit (GE Healthcare, Buckinghamshire, UK), complementary DNAs (cDNAs) were 
synthesized from 2 mg of each total RNA sample using high-capacity RNA-to-DNA kits 
(Applied Biosystems, Foster City, CA). Each cDNA sample was diluted 4-fold before 
PCR amplification. TaqMan gene expression assays (Applied Biosystems) guided the 
design of primers. RT-PCR was performed using a 7900HT Fast RT-PCR System 
(Applied Biosystems) and TaqMan Fast Advanced Master Mix (Applied Biosystems) 
according to the manufacturer’s instructions. Amplification consisted of an initial 10-min 
denaturation phase at 95°C, followed by 40 cycles of denaturation at 95°C for 10 s, 
annealing at 60°C for 40 s, and extension at 72°C for 10 s. Degree of expression of each 
target gene was normalized relative to expression of the mRNA encoding glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) determined in the same sample to permit 
  
 
informative between-sample comparisons. Assays were performed in triplicate. 
 
Statistical analysis 
Continuous data are expressed as the mean (± standard deviation) or median (range), and 
were analyzed using the Mann-Whitney U test. The chi-squared test or Fisher’s exact test 
was used to analyze categorical variables. A two-sided P value <0.05 was considered to 
indicate significance in all analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Results  
Chronological changes in weight regeneration of each liver lobe after surgery 
Chronological changes in liver weight regeneration after surgery are shown in Figure 3. 
The ratio of CL weight to body weight (CL/BW) continued to increase up to postoperative 
day (POD)7 in the PVL+C group; however, the growth of CL/BW terminated at POD2 
in the PVL group and remained unchanged in the SHAM group. CL/BW at POD7 was 
0.31 ± 0.02% in the SHAM group, 1.22 ± 0.18% in the PVL group, and 2.41 ± 0.33% in 
the PVL+C group, respectively (SHAM vs PVL, P<0.01; PVL vs PVL+C, P<0.01; 
SHAM vs PVL +C, P<0.01). With regard to LLL, i.e., the embolized (congested) liver, 
LLL weight to body weight ratio (LLL/BW) continued to decrease up to POD7 in the 
PVL+C group but reached nadir at POD2 in the PVL group and remained unchanged in 
the SHAM group. LLL/BW at POD7 was 1.13 ± 0.15% in the SHAM group, 0.67 ± 0.08% 
in the PVL group, and 0.35 ± 0.03% in the PVL+C group (SHAM vs PVL, P<0.01; PVL 
vs PVL+C, P<0.01; SHAM vs PVL+C, P<0.01). In contrast, the weight regeneration of 
ML, which was embolized alone in the PVL or PVL+C group, showed no significant 
difference between the PVL and PVL+C groups (Figure 3). Similarly, chronological 
changes in weight regeneration of the RL, which was embolized alone in the PVL or 
PVL+C groups, did not show any significant difference between the PVL and PVL+C 
groups (data not shown).   
 
Laboratory tests on serum 
Chronological changes in serum ALT, AST, and T.Bil levels in each group are shown in 
Figure 4. A remarkable elevation of these variables was observed at POD1 in the PVL+C 
group. A >5-fold elevation in ALT and AST or >2-fold elevation in T.Bil were observed 
  
 
in the PVL+C group in comparison with the PVL group at POD1 (P<0.01). However, the 
PVL+C group values rapidly recovered and did not show any significant differences 
compared to the other groups at POD3 and thereafter. 
 
Histologic and immunohistochemical assessment 
Representative photomicrographs at POD1 and POD7 (HE) are shown in Figure 5. The 
most marked microscopic abnormalities at POD1 were seen in the LLL of the PVL+C 
group, including hepatocyte atrophy, sinusoidal congestion, and cytoplasmic vacuolation 
(Figure 5a), with fibrosis ensuing by POD7 (Figure 5b). Although these findings were 
observed after PVL alone, the grade of each was severer in the PVL+C group than in the 
PVL group. Furthermore, fibrosis was not observed at any time points in the PVL group. 
A comparison of Ki-67 expression in the CL between the PVL and PVL+C groups showed 
that the maximum Ki-67-positive hepatocyte counts during the 7 days after surgery were 
significantly greater in the PVL+C than in the PVL (PVL+C vs PVL, P<0.01; Figure 6a 
and 6b). Furthermore, Ki-67 positive hepatocyte counts peaked at POD1 and thereafter 
decreased rapidly to the same level as that in the SHAM group in the PVL group, whereas 
Ki-67-positive hepatocyte counts increased up to POD3 and thereafter decreased 
gradually in the PVL+C group. Consequently, Ki-positive hepatocyte counts at POD7 
were significantly greater in the PVL+C group than in the PVL group (40 ± 7 vs 14 ± 3, 
P<0.01). These findings suggest that regenerative stimulation of the CL caused by 
PVL+C is greater in magnitude and more prolonged in duration than that caused by PVL 
alone. 
Maximum counts of TUNEL-positive hepatocytes in the LLL were observed at POD1 in 
both the PVL and PVL+C groups. Furthermore, these counts did not differ between the 
  
 
two groups at any time point (Figure 6c and 6d). 
 
Up-regulation of the mRNA expression of pro-inflammatory cytokines 
Molecular analysis of the FLR (represented by the CL) demonstrated larger increases in 
the TNF-α, IL-6, and cyclin D1 mRNA expression in the PVL than in the PVL+C group 
at 48 h after surgery, while expression of mRNA encoding IL1-β was higher in the PVL+C 
group (P<0.01, Figure 7a to c). Expression for IL1-β at 24 h, HGF at 48 h, and TNF-α, 
IL-6, and cyclin D1 on POD3 were higher in the PVL+C than in the PVL group (P<0.01). 
On postoperative day 7, IL-6 expression was higher in the PVL+C than in the PVL group 
(P<0.05). Cyclin C expression was increased at 24 h after surgery, but showed no 
significant difference between the two groups at that time point. 
To summarize these findings, a greater and more prolonged expression of TNF-α and 
IL-6 were observed in the PVL+C group than in the PVL group. Furthermore, a greater 
magnitude of maximum expression of HGF and IL1-β was observed in the PVL+C group 
than in the PVL group. However, a difference in the maximum expression of cyclin C or 
cyclin D1 was not observed among the groups, although the expression of cyclin D1 in 
the PVL+C group was delayed. A significant difference in cyclin D1 expression between 
the PVL and PVL+C groups was observed at POD2 or POD3, but not on the other days. 
 
 
 
 
 
 
  
 
Discussion 
To the best of our knowledge, there have been no reports of an animal model to investigate 
the beneficial effect of congestion in addition to PVE/L; therefore, we developed a rat 
model of PVL+C. Our model showed that a greater FLR expansion and more severe 
atrophy of the embolized/congested lobe were achieved by PVL+C compared with PVL 
alone. Hence, we considered that the findings obtained from our rat model could be 
reflected in the clinical setting. 
In the present study, we corroborated that PVL+C caused severe devastation of the 
planned resected liver than PVL alone, and further demonstrated that the expression of 
several mediators promoting liver regeneration in FLR were greater and/or more 
prolonged in the PVL+C group than in the PVL group.  
Increased devastation of the LLL in the PVL+C group compared to the PVL group was 
confirmed not only quantitatively but also qualitatively. A reduction in the LLL weight as 
well as histologically-proven impairment including sinusoidal congestion, cytoplasmic 
vacuolization, and fibrosis were more severe and sustained in the PVL+C than in the PVL. 
Furthermore, significantly higher values of the results from the serum liver function test 
were considered to reflect the severer qualitative devastation of the LLL caused by 
congestion in addition to PVL. The functional demand of the devastated part of the liver 
was reported to shift to another portion (15). This functional shift was considered to serve 
as regenerative stimulation to the intact liver. Therefore, the more severe the devastation 
of the embolized liver, the larger the FLR. PVL reportedly promotes hepatocyte apoptosis 
in the embolized liver (15). However, hepatocyte apoptosis in the LLL assessed by 
TUNEL staining did not show any difference between the PVL and PVL+C groups in the 
present study. Thus, the increased devastation caused by congestion in addition to PVE/L 
  
 
was brought on by factors other than apoptosis. On the other hand, several clinical studies 
have demonstrated that hepatic vein embolization combined with PVE/L and the ALPPS 
procedure increased the mortality and/or morbidity rates compared with PVE/L alone. In 
our model, venous congestion was applied to only one of the four embolized liver lobes. 
Nevertheless, a >5-fold elevation in the serum transaminase level was observed in the 
PVL+C group compared with the PVL group. In clinical settings, hepatic vein 
embolization combined with PVE/L and the ALPPS procedure affects all embolized liver 
lobes. Therefore, a more pronounced hepatic parenchymal injury might be considered to 
occur in the clinical setting than in our model, leading to more frequent mortality and/or 
morbidity than with PVE/L alone. 
With regards to the chemical mediators affecting liver regeneration, we examined the 
mRNA expression of TNF-α, IL-6, HGF, cyclin C, cyclin D1, and IL1-β in the FLR to 
explore the molecular mechanisms of regeneration in the CL. These cytokines have been 
reported to be important for hepatocyte proliferation and are thus considered suitable for 
investigating the possible mechanisms of the beneficial effect of congestion in addition 
to PVE/L, as well as assessing the reliability of our model (16). The mRNA expression 
of TNF-α, IL-6, and HGF were up-regulated significantly in the PVL+C group compared 
to the PVL group, but not in the SHAM group. The cytokines, including TNF-α, IL-6, 
and HGF, act as mitogenic stimuli on hepatocytes during regeneration (16,17). TNF-α 
and IL-6 are particularly important in initiating liver regeneration. Produced by activated 
Kupffer cells, these pro-inflammatory cytokines promote transition of hepatocytes from 
the G0 to the G1 phase (18-20). Our findings indicate that venous congestion in addition 
to PVE/L caused increased expression and/or a more prolonged up-regulation of these 
pro-inflammatory cytokines than PVE/L alone. Interestingly, PVL+C resulted in a 
  
 
delayed upregulation of cyclin D1 mRNA compared to PVL alone, even though the 
maximum magnitude of cyclin D1 expression did not differ among the PVL and PVL+C 
groups. This important cell-cycle regulatory protein can stimulate cell passage through 
the G1 checkpoint into the S phase (21). As previously reported, liver regeneration is a 
changing process consisting of multiple intracellular events that show complex 
interactions involving cytokines and growth factors (16,22). Our findings are consistent 
with such a process and suggests that venous congestion induces changes in cytokines 
and regulatory proteins that contribute to the increase in FLR volume after PVL+C. 
Previous studies have reported that high-mobility group protein 1 (HMGB-1) can 
stimulate inflammatory cytokines in response to internally detected biologic threats (23). 
As such, many details of the mechanisms by which venous congestion increases cytokine 
expression remain unclear. We believe that the present rat model of PVL+C could be 
useful for future studies to clarify these complex relationships between venous congestion 
and inflammation. 
The present study has several limitations. Firstly, our model does not include a liver 
partition procedure, although it was designed with the aim to investigate the additional 
effect of hepatic vein embolization as well as ALPPS to PVE/L alone. The liver partition 
procedure itself is considered to produce a stimulatory effect for liver regeneration (24). 
Unfortunately, the effect of liver partition procedure itself cannot be assessed by our 
model. Second, the volume of intact liver in our model may be too large compared to that 
in a clinical setting. Our rat model of PVL+C was designed to simulate a 90% 
hepatectomy in rats. As we previously reported, rats can survive a 90% hepatectomy, in 
which all hepatic lobes except for entire CL are removed (25). In the clinical setting, 
hepatic vein embolization combined with the PVE/L or ALPPS procedure is usually 
  
 
applied for patients who are considered unlikely to survive surgery because of a very 
small FLR and/or insufficient FLR expansion. Therefore, we should have generated a 
fatal hepatectomy model, such as a 95% hepatectomy model, in which all hepatic lobes 
except for the posterior CL are removed as rats cannot survive this surgery, as previously 
reported (25). However, a PVL model to simulate a 95% hepatectomy in rats requires 
separate ligation of the anterior CL portal branch in addition to the RL, RML, LML, and 
LLL branches. Separate isolation of the anterior CL portal branch is quite difficult because 
divergence of the anterior and posterior CL portal branches is almost always entirely 
buried in the hepatic parenchyma in rats. Therefore, we did not simulate a 95% 
hepatectomy. Third, we did not assess cytokine profiles within 24 hours after surgery. 
Several previous reports have shown that expression of mediators affecting liver 
regeneration is initiated immediately after surgery, within several hours (26,27). However, 
the present study results suggest that congestion in addition to PVL causes greater and 
more prolonged expression of these mediators than PVL alone, which we consider 
provides evidence for a difference between PVL+C and PVL alone. Even if these 
limitations, we believe that the present study provides important new information 
concerning the significance of congestion in addition to PVL for stimulating FLR 
regeneration.  
In conclusion, the PVL+C rat model was considered useful to investigate the beneficial 
effect of congestion in addition to PVC. PVL+C resulted in more severe devastation of 
the embolized liver, as well as increased and more prolonged expression of factors 
promoting liver regeneration in the non-embolized liver compared with PVL alone, 
leading to earlier and more robust FLR regeneration.  
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Figure Legends 
 
Fig. 1. Surgical procedure for PVL and in PVL with venous congestion (PVL+C) rat 
models. For PVL (a), PVL is performed for the right and left middle lobes, left lateral 
lobe, and right lobe. For PVL+C (b), the same PVL procedure is performed followed by 
induction of venous congestion by ligating the left lateral hepatic vein. The preoperative 
rat liver anatomy is shown in panel c (sham operation). PVL, portal vein ligation; CL, 
caudate lobe; RML, right middle lobe; LML, left middle lobe; LLL, left lateral lobe; PV, 
portal vein; IVC, inferior vena cava; HA, hepatic artery; LLHV, left lateral hepatic vein. 
 
Fig. 2. Experimental design. The 150 study rats were randomized into three groups of 50, 
and sacrificed at different intervals of time: immediately after surgery, and 24 h, 48 h, 3 
d, and 7 d later (10 rats per group at each time point). 
 
Fig. 3. Hepatic lobe weights as percentages of BW for CL (a), ML (b), and LLL(c) after 
SHAM, PVL, and PVL+C procedures. CL weights relative to body weights are 
significantly greater after PVL and PVL+C at postoperative days 3 and 7 than those for 
the SHAM group. This relative CL weight is significantly greater for the PVL+C than the 
PVL group at postoperative day 7. Values are expressed as mean ± standard deviation. #, 
P<0.01 for the PVL+C group vs. the PVL group; *, P<0.01 for the PVL+C group vs. the 
SHAM group; **, P<0.01 for the PVL group vs. the SHAM group. PVL, portal vein 
ligation; CL, caudate lobe; LML, middle lobe; LLL, left lateral lobe; SHAM, sham 
operation; BW, body weight; PVL+C, portal vein ligation with venous congestion. 
 
  
 
Fig. 4. Serial changes in postoperative liver function test results. AST, ALT, and T.Bil are 
significantly higher in the PVL+C than in the PVL group at 24 h postoperatively. Results 
are expressed as the median (range) of 10 rats per group at each time point. *, P<0.01 for 
the PVL+C group vs. the PVL group. AST, aspartate aminotransferase; ALT, alanine 
aminotransferase; T.Bil, total bilirubin; PVL, portal vein ligation; PVL+C, portal vein 
ligation with venous congestion. 
 
Fig. 5. Representative microscopic images of FLR and LLL for the PVL and PVL+C 
groups at 24 h and 7 d postoperatively. (a) In the PVL+C group, atrophy, sinusoidal 
congestion, and cytoplasmic vacuolation are observed in the LLL at 24 h. (b) In the same 
group, severe fibrosis is observed in the LLL at 7 d. Scale bar = 100 μm. (a) and (b): 
hematoxylin and eosin stain, original magnification ×200. FLR, future liver remnant;  
LLL, left lateral lobe; PVL, portal vein ligation; PVL+C, portal vein ligation with venous 
congestion. 
 
Fig. 6. Ki-67-positive cells in the CL (a,b) and TUNEL-positive cells in the LLL (c,d) 
over time following surgery. (a) Ki67 staining in CL tissue samples taken from PVL and 
PVL+C rats at 24 h and 3 d. Arrows indicate positive cells. (b) The percentage of Ki-67-
positive CL cells at postoperative days 3 and 7 is significantly higher in the PVL+C group 
than in the PVL group. (c) TUNEL staining in the LLL tissue samples taken from PVL 
and PVL+C rats at 3 d. Arrows indicate positive cells. (d) The percentage of TUNEL-
positive cells is not significantly different between the PVL+C and PVL groups at any 
time point. #, P<0.01 for the PVL+C vs. the PVL group; ##, P<0.01 for the PVL vs. the 
PVL+C group. CL, caudate lobe; PVL, portal vein ligation; PVL+C, portal vein ligation 
  
 
with venous congestion; TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end 
labeling; LLL, left lateral lobe; SHAM, sham operation. 
 
Fig. 7. Expression of mRNAs for cytokines in CL tissue after the procedures. Expression 
was determined using quantitative real-time RT-PCR and standardized to GAPDH mRNA 
expression. (a) Relative expression of TNF-α and IL-6 mRNAs is significantly higher in 
the PVL than the PVL+C group at 48 h after surgery, while on postoperative day 3 these 
are significantly higher in the PVL+C than the PVL group. (b) Relative expression of 
cyclin D1 mRNA is significantly higher in the PVL than PVL+C group at 48 h after 
surgery, while on postoperative day 3 this is significantly higher in the PVL+C than the 
PVL group. (c) Relative expression of IL1-β mRNA at 24 h and of HGF at 48 h is 
significantly higher in the PVL+C than the PVL group. #, P<0.01 for the PVL+C vs. the 
PVL group; *, P<0.01 for the PVL+C vs. the SHAM group; **, P<0.01 for the PVL vs. 
the SHAM group. mRNA, messenger RNA; CL, caudate lobe; PVL, portal vein ligation; 
PVL+C, portal vein ligation with venous congestion; SHAM, sham operation; RT-PCR, 
real-time reverse-transcription polymerase chain reaction; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; HGF, 
hepatocellular growth factor; IL1-β, interleukin-1β. 
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